1378 related articles for article (PubMed ID: 14566661)
21. Transitional cell carcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer.
Wood DP; Montie JE; Pontes JE; VanderBrug Medendorp S; Levin HS
J Urol; 1989 Feb; 141(2):346-9. PubMed ID: 2913357
[TBL] [Abstract][Full Text] [Related]
22. The management of urethral transitional cell carcinoma after radical cystectomy for invasive bladder cancer.
Clark PE; Stein JP; Groshen SG; Miranda G; Cai J; Lieskovsky G; Skinner DG
J Urol; 2004 Oct; 172(4 Pt 1):1342-7. PubMed ID: 15371837
[TBL] [Abstract][Full Text] [Related]
23. Intravesical instillations with bacillus calmette-guérin for the treatment of carcinoma in situ involving prostatic ducts.
Palou Redorta J; Schatteman P; Huguet Pérez J; Segarra Tomás J; Rosales Bordes A; Algaba F; Villavicencio Mavrich H
Eur Urol; 2006 May; 49(5):834-8; discussion 838. PubMed ID: 16426729
[TBL] [Abstract][Full Text] [Related]
24. [Can the prostatic capsule be preserved during cystectomy for bladder tumors: a study of urethral and prostatic involvement in the cystectomy specimens].
Plante P; Lesourd A; Blanchet P; Castagnola C; Coloby P; Daffer N; Davin JL; Desgrandchamps F; Irani J; Marechal JM; Mottet N; Pariente JL
Prog Urol; 1998 Feb; 8(1):47-50. PubMed ID: 9533151
[TBL] [Abstract][Full Text] [Related]
25. Incidental prostate cancer in patients with bladder urothelial carcinoma: comprehensive analysis of 1,476 radical cystoprostatectomy specimens.
Bruins HM; Djaladat H; Ahmadi H; Sherrod A; Cai J; Miranda G; Skinner EC; Daneshmand S
J Urol; 2013 Nov; 190(5):1704-9. PubMed ID: 23707451
[TBL] [Abstract][Full Text] [Related]
26. Outcomes in patients with pathological carcinoma in situ only disease at radical cystectomy.
Hassan JM; Cookson MS; Smith JA; Johnson DL; Chang SS
J Urol; 2004 Sep; 172(3):882-4. PubMed ID: 15310989
[TBL] [Abstract][Full Text] [Related]
27. Carcinoma in situ and tumor multifocality predict the risk of prostatic urethral involvement at radical cystectomy in men with transitional cell carcinoma of the bladder.
Nixon RG; Chang SS; Lafleur BJ; Smith JA JA; Cookson MS
J Urol; 2002 Feb; 167(2 Pt 1):502-5. PubMed ID: 11792906
[TBL] [Abstract][Full Text] [Related]
28. What is the ratio of urethral recurrence risk after radical cystoprostatectomy for bladder cancer?
Sevin G; Soyupek S; Armağan A; Hoşcan MB; Dilmen C; Tükel O
Int Urol Nephrol; 2004; 36(4):523-7. PubMed ID: 15787329
[TBL] [Abstract][Full Text] [Related]
29. The role of preoperative prostatic urethral biopsy in clinical decision-making at the time of radical cystectomy.
Gaya JM; Matulay J; Badalato GM; Holder DD; Hruby G; McKiernan J
Can J Urol; 2014 Apr; 21(2):7228-33. PubMed ID: 24775577
[TBL] [Abstract][Full Text] [Related]
30. Importance of early treatment of transitional cell carcinoma of prostatic ducts.
Wishnow KI; Ro JY
Urology; 1988 Jul; 32(1):11-2. PubMed ID: 3388655
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of transurethral biopsy for staging the prostatic urethra before radical cystectomy.
von Rundstedt FC; Lerner SP; Godoy G; Amiel G; Wheeler TM; Truong LD; Shen SS
J Urol; 2015 Jan; 193(1):58-63. PubMed ID: 25106902
[TBL] [Abstract][Full Text] [Related]
32. Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery.
Revelo MP; Cookson MS; Chang SS; Shook MF; Smith JA; Shappell SB
J Urol; 2004 Feb; 171(2 Pt 1):646-51. PubMed ID: 14713778
[TBL] [Abstract][Full Text] [Related]
33. Pathologic assessment and clinical significance of prostatic involvement by transitional cell carcinoma and prostate cancer.
Lerner SP; Shen S
Urol Oncol; 2008; 26(5):481-5. PubMed ID: 18774459
[TBL] [Abstract][Full Text] [Related]
34. [Urethral tumor recurrence following radical cystoprostatectomy--an indication for primary cystoprostato-urethrectomy?].
Gökcebay E; Riedmiller H; Stöckle M; Hohenfellner R
Urologe A; 1989 Jul; 28(4):199-203. PubMed ID: 2763395
[TBL] [Abstract][Full Text] [Related]
35. Commentary on prostate and urothelial carcinoma in cystoprostatectomy specimens.
Lotan Y
J Urol; 2008 May; 179(5 Suppl):S33-4. PubMed ID: 18405746
[No Abstract] [Full Text] [Related]
36. The frequency of prostatic involvement in radical cystectomy specimens for transitional cell carcinoma of the bladder.
Basiri A; Ozhand A; Karami H; Parham HA; Safarinejad MR
J Pak Med Assoc; 2008 Sep; 58(9):479-81. PubMed ID: 18846793
[TBL] [Abstract][Full Text] [Related]
37. Superficial urothelial cancer in the prostatic urethra.
Kirkali Z; Canda AE
ScientificWorldJournal; 2006 Feb; 6():2603-10. PubMed ID: 17619737
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for mucosal prostatic urethral involvement in superficial transitional cell carcinoma of the bladder.
Mungan MU; Canda AE; Tuzel E; Yorukoglu K; Kirkali Z
Eur Urol; 2005 Nov; 48(5):760-3. PubMed ID: 16005563
[TBL] [Abstract][Full Text] [Related]
39. [Prostatic urothelial location of a tumor of the bladder].
Coulange C; Lechevallier E; de Fromont M
Prog Urol; 1997 Feb; 7(1):128-31. PubMed ID: 9116731
[TBL] [Abstract][Full Text] [Related]
40. [Urethral recurrence of invasive carcinoma following BCG treatment for bladder Ca in situ].
Ruoppolo M; Gozo M; Milesi R; Spina R; Fragapane G
Urologia; 2010; 77 Suppl 17():72-7. PubMed ID: 21308679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]